Condition

Islet Transplantation

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 8 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials8

Recruiting0

Common interventions9

Lead sponsors shown8

Clinical trials

8 shown

Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow TherapyNCT05973734 · 2024-04-15

ENROLLING_BY_INVITATION

CGM Use in Islet Transplant RecipientsNCT03427931 · 2018-02-01

COMPLETED

Nephrologic Prognosis 10 Years After Diabetes Cell TherapyNCT02627690 · 2014-11-03

COMPLETED

A Comparison of Strict Glucose Control With Usual Care at the Time of Islet Cell TransplantationNCT01123122 · 2011-09-01

WITHDRAWN

Extended Follow-Up After Islet Transplantation in T1DNCT01369082 · 2011-05-01

COMPLETED

Effect of Sitagliptin on Graft Function Following Islet TransplantationNCT00853944 · 2009-07-01

TERMINATED

Imaging of Islet Transplantation With PET and MRTNCT00417131 · 2006-10-01

COMPLETED

Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell GraftsNCT00409461

TERMINATED

Common interventions

ATG-Sirolimus-TacrolimusDRUG1 Continuous Glucose Monitor (CGM)OTHER1 Infusion of concomitant Donor Derived Vertebral Bone MarrowBIOLOGICAL1 Infusion of recipient T regulatory cellBIOLOGICAL1 islet transplantedOTHER1 Maintenance Immunosuppressive TreatmentDRUG1 non islet transplantedOTHER1 sitagliptinDRUG1 Strict glucose controlOTHER1

Leading sponsors

National Institute of Allergy and Infectious Diseases (NIAID) 1 Stanford University 1 Universitair Ziekenhuis Brussel 1 University Hospital, Lille 1 University of British Columbia 1 University of Virginia 1 Uppsala University Hospital 1 Vancouver Coastal Health 1

Trial status mix

COMPLETED4

TERMINATED2

ENROLLING_BY_INVITATION1

WITHDRAWN1

Phase mix

NA3

PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.